Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Looking for the best places to invest for maximum returns in 2023? Discover effective strategies to enhance your investment portfolio.
14,465 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A practical, investor-focused look at delcath (dcth) 2025 earnings prospects. We break down the catalysts, risks, and...
Binance Smart Chain transaction fees dropped to a fresh multi-month low, reinforcing a pattern that traders say could...
As 2025 earnings season unfolds, AvePoint faces a pivotal moment in cloud data governance and SaaS expansion. This gu...
A look at WWII-era weapons that helped allies reveals how innovation and mass production built a durable defense base...
Institutional moves are reshaping exposure to China as the market resets. This article explains what happened with mi...
NuScale Power has seen wild swings, but the story isn’t just nostalgia for a boom. This piece breaks down the odds of...
Bitcoin staged a rapid reversal after a sharp drop tied to Middle East tensions, rebounding into the high 60,000s as ...
A 49-year-old military veteran weighs early retirement with a guaranteed $8,000 monthly pension and a $1.2 million ne...
A drone maker sparked a quick rally before giving up gains as contract news hit. This piece breaks down why aeroviron...
Blackstone's flagship private-credit fund drew heavier redemptions than typical, underscoring strain in private credi...
Kensho Clean Power ETF (CNRG) surged 68% over the last year but fell 9% in February, as traders await a Fed signal th...